Ligand Pharmaceuticals LGND
NASDAQ LGND
$314.78 +8.38 (+2.73%)
At close: Oct 21, 2026 · 4:00 PM EDT

Ligand Pharmaceuticals (LGND) Long-Term Debt Repayments (2010 - 2026)

Updated

Ligand Pharmaceuticals (LGND) posted Long-Term Debt Repayments of $7,000 for Q2 2026, unchanged from $7,000 a year earlier and unchanged from the prior quarter.

Analysis

Ligand Pharmaceuticals (LGND) Long-Term Debt Repayments (2010 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Long-Term Debt Repayments at Ligand Pharmaceuticals was $27,000, down 10.0% year-over-year; for FY2025, it was $27,000, up 8.0% from FY2024.

  • Annual Long-Term Debt Repayments shows a five-year compound annual growth rate of -83.5% (FY2020 to FY2025).
  • In prior years, Ligand Pharmaceuticals' Long-Term Debt Repayments was $25,000 in FY2024 (-100.0%), $76.85 million in FY2023 (-70.5%), $260.95 million in FY2022 (+67.5%) and $155.76 million in FY2021 (-29.9%).
  • Quarterly Long-Term Debt Repayments has run from a low of $4,000 in Q2 2024 to a high of $163.36 million in Q1 2022 over five years.
  • On a year-over-year basis, Long-Term Debt Repayments increased in three of the last six quarters, with growth averaging 15.3%.
  • The strongest year-over-year quarter for Long-Term Debt Repayments in the past five years was Q2 2025, with growth of 75.0%; the weakest was Q2 2024, with a decline of 100.0%.
  • According to Business Quant data, Long-Term Debt Repayments for the three prior quarters was $7,000 (Q1 2026), $7,000 (Q4 2025) and $6,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 873.00 Mn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 1.00 Mn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 2.00 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 5.00 Mn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 20.00 Mn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 2.46 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 17.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Ligand Pharmaceuticals 6.33 Bn 2.80 Bn - 7,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7,000.00
Mar 31, 2026 7,000.00
Dec 31, 2025 7,000.00
Sep 30, 2025 6,000.00
Jun 30, 2025 7,000.00
Mar 31, 2025 7,000.00
Dec 31, 2024 6,000.00
Sep 30, 2024 10,000.00
Jun 30, 2024 4,000.00
Mar 31, 2024 5,000.00
Dec 31, 2023 5,000.00
Sep 30, 2023 14,000.00
Jun 30, 2023 76.87 Mn
Mar 31, 2023 13,000.00
Dec 31, 2022 54,000.00
Sep 30, 2022 37.65 Mn
Jun 30, 2022 59.93 Mn
Mar 31, 2022 163.37 Mn
Sep 30, 2021 2.38 Mn
Jun 30, 2021 49.95 Mn
API Access

Ligand Pharmaceuticals Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=LGND&period=max&api_key=YOUR_API_KEY